DR3 signaling protects against cisplatin nephrotoxicity mediated by tumor necrosis factor

American Journal of Pathology

Volumn 180, Issue 4, 2012, Pages 1454-1464

  Al Lamki, Rafia S ^a   Lu, Wanhua ^a   Finlay, Sarah ^a   Twohig, Jason P ^d   Wang, Eddie C Y ^d   Tolkovsky, Aviva M ^b,c   Bradley, John R ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CISPLATIN; DEATH RECEPTOR 3; ILOMASTAT; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR LIKE FACTOR 1A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MOUSE; NEPHROTOXICITY; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; CISPLATIN; DIPEPTIDES; DRUG INTERACTIONS; EPITHELIAL CELLS; KIDNEY TUBULES; KIDNEY TUBULES, PROXIMAL; LIGANDS; MICE; MICE, MUTANT STRAINS; NF-KAPPA B; ORGAN CULTURE TECHNIQUES; PHOSPHORYLATION; PROTEASE INHIBITORS; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84859049504     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.01.003     Document Type: Article

References (39)

1. E.C. Wang, A. Thern, A. Denzel, J. Kitson, S.N. Farrow, M.J. Owen DR3 regulates negative selection during thymocyte development Mol Cell Biol 21 2001 3451 3461
2. A.M. Chinnaiyan, K. O'Rourke, G.L. Yu, R.H. Lyons, M. Garg, D.R. Duan, L. Xing, R. Gentz, J. Ni, V.M. Dixit Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95 Science 274 1996 990 992
3. J. Kitson, T. Raven, Y.P. Jiang, D.V. Goeddel, K.M. Giles, K.T. Pun, C.J. Grinham, R. Brown, S.N. Farrow A death-domain-containing receptor that mediates apoptosis Nature 384 1996 372 375
4. S.A. Marsters, J.P. Sheridan, C.J. Donahue, R.M. Pitti, C.L. Gray, A.D. Goddard, K.D. Bauer, A. Ashkenazi Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B Curr Biol 6 1996 1669 1676
5. J.L. Bodmer, K. Burns, P. Schneider, K. Hofmann, V. Steiner, M. Thome, T. Bornand, M. Hahne, M. Schroter, K. Becker, A. Wilson, L.E. French, J.L. Browning, H.R. MacDonald, J. Tschopp TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95) Immunity 6 1997 79 88
6. G.R. Screaton, X.N. Xu, A.L. Olsen, A.E. Cowper, R. Tan, A.J. McMichael, J.I. Bell LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing Proc Natl Acad Sci U S A 94 1997 4615 4619
7. M. Croft The role of TNF superfamily members in T-cell function and diseases Nat Rev Immunol 9 2009 271 285
8. I.E. Wertz, V.M. Dixit Regulation of death receptor signaling by the ubiquitin system Cell Death Differ 17 2010 14 24
9. G. Bamias, M. Mishina, M. Nyce, W.G. Ross, G. Kollias, J. Rivera-Nieves, T.T. Pizarro, F. Cominelli Role of TL1A and its receptor DR3 in two models of chronic murine ileitis Proc Natl Acad Sci U S A 103 2006 8441 8446
10. M.A. Cassatella, G. Pereira-da-Silva, I. Tinazzi, F. Facchetti, P. Scapini, F. Calzetti, N. Tamassia, P. Wei, B. Nardelli, V. Roschke, A. Vecchi, A. Mantovani, L.M. Bambara, S.W. Edwards, A. Carletto Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis J Immunol 178 2007 7325 7333
11. K.A. Papadakis, D. Zhu, J.L. Prehn, C. Landers, A. Avanesyan, G. Lafkas, S.R. Targan Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes J Immunol 174 2005 4985 4990
12. M.J. Bull, A.S. Williams, Z. Mecklenburgh, C.J. Calder, J.P. Twohig, C. Elford, B.A. Evans, T.F. Rowley, T.J. Slebioda, V.Y. Taraban, A. Al-Shamkhani, E.C. Wang The death receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis J Exp Med 205 2008 2457 2464
13. H. Takedatsu, K.S. Michelsen, B. Wei, C.J. Landers, L.S. Thomas, D. Dhall, J. Braun, S.R. Targan TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation Gastroenterology 135 2008 552 567
14. F. Meylan, T.S. Davidson, E. Kahle, M. Kinder, K. Acharya, D. Jankovic, V. Bundoc, M. Hodges, E.M. Shevach, A. Keane-Myers, E.C. Wang, R.M. Siegel The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases Immunity 29 2008 79 89
15. J.P. Twohig, M.I. Roberts, N. Gavalda, E.L. Rees-Taylor, A. Giralt, D. Adams, S.P. Brooks, M.J. Bull, C.J. Calder, S. Cuff, A.A. Yong, J. Alberch, A. Davies, S.B. Dunnett, A.M. Tolkovsky, E.C. Wang Age-dependent maintenance of motor control and corticostriatal innervation by death receptor 3 J Neurosci 30 2010 3782 3792
16. R.S. Al-Lamki, J. Wang, S. Thiru, N.R. Pritchard, J.A. Bradley, J.S. Pober, J.R. Bradley Expression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplants Am J Pathol 163 2003 401 411
17. R.S. Al-Lamki, J. Wang, A.M. Tolkovsky, J.A. Bradley, J.L. Griffin, S. Thiru, E.C. Wang, E. Bolton, W. Min, P. Moore, J.S. Pober, J.R. Bradley TL1A both promotes and protects from renal inflammation and injury J Am Soc Nephrol 19 2008 953 960
18. N. Pabla, Z. Dong Cisplatin nephrotoxicity: mechanisms and renoprotective strategies Kidney Int 73 2008 994 1007
19. X. Yao, K. Panichpisal, N. Kurtzman, K. Nugent Cisplatin nephrotoxicity: a review Am J Med Sci 334 2007 115 124
20. T.W. Jones, S. Chorpa, J.S. Kaufman, W. Flamenbaum, B.F. Trump Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat: enzyme histochemical studies Toxicol Pathol 13 1985 296 305
21. J. Deng, Y. Kohda, H. Chiao, Y. Wang, X. Hu, S.M. Hewitt, T. Miyaji, P. McLeroy, B. Nibhanupudy, S. Li, R.A. Star Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury Kidney Int 60 2001 2118 2128
22. G. Ramesh, W.B. Reeves TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity J Clin Invest 110 2002 835 842
23. Z. Dong, S.S. Atherton Tumor necrosis factor-alpha in cisplatin nephrotoxicity: a homebred foe? Kidney Int 72 2007 5 7
24. G. Ramesh, W. Brian Reeves Cisplatin increases TNF-alpha mRNA stability in kidney proximal tubule cells Ren Fail 28 2006 583 592
25. G. Ramesh, S.R. Kimball, L.S. Jefferson, W.B. Reeves Endotoxin and cisplatin synergistically stimulate TNF-alpha production by renal epithelial cells Am J Physiol Renal Physiol 292 2007 F812 F819
26. K. Tsuruya, T. Ninomiya, M. Tokumoto, M. Hirakawa, K. Masutani, M. Taniguchi, K. Fukuda, H. Kanai, K. Kishihara, H. Hirakata, M. Iida Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death Kidney Int 63 2003 72 82
27. R.S. Al-Lamki, J. Wang, P. Vandenabeele, J.A. Bradley, S. Thiru, D. Luo, W. Min, J.S. Pober, J.R. Bradley TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury FASEB J 19 2005 1637 1645
28. S. Ernest, E. Bello-Reuss Expression and function of P-glycoprotein in a mouse kidney cell line Am J Physiol 269 1995 C323 C333
29. Y. Gavrieli, Y. Sherman, S.A. Ben-Sasson Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation J Cell Biol 119 1992 493 501
30. B. Zhang, G. Ramesh, C.C. Norbury, W.B. Reeves Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells Kidney Int 72 2007 37 44
31. C.C. Solorzano, R. Ksontini, J.H. Pruitt, T. Auffenberg, C. Tannahill, R.E. Galardy, G.P. Schultz, S.L. MacKay, E.M. Copeland 3rd, L.L. Moldawer A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality Shock 7 1997 427 431
32. U. Sartorius, I. Schmitz, P.H. Krammer Molecular mechanisms of death-receptor-mediated apoptosis Chembiochem 2 2001 20 29
33. Q. Wei, G. Dong, J. Franklin, Z. Dong The pathological role of Bax in cisplatin nephrotoxicity Kidney Int 72 2007 53 62
34. R.K. Tadagavadi, W.B. Reeves Endogenous IL-10 attenuates cisplatin nephrotoxicity: role of dendritic cells J Immunol 185 2010 4904 4911
35. A.A. Beg, D. Baltimore An essential role for NF-kappaB in preventing TNF-alpha-induced cell death Science 274 1996 782 784
36. P. Ramakrishnan, D. Baltimore Sam68 is required for both NF-κB activation and apoptosis signaling by the TNF receptor Mol Cell 43 2011 167 179
37. J.S. Pober, W. Min, J.R. Bradley Mechanisms of endothelial dysfunction, injury, and death Annu Rev Pathol 4 2009 71 95
38. K.D. Taganov, M.P. Boldin, K.J. Chang, D. Baltimore NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses Proc Natl Acad Sci U S A 103 2006 12481 12486
39. J. Luo, T. Tsuji, H. Yasuda, Y. Sun, Y. Fujigaki, A. Hishida The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats Nephrol Dial Transplant 23 2008 2198 2205